Examining the genital microbiome of male partners of women with recurrent bacterial vaginosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the role of the male partner's genital microbiome in the recurrence of bacterial vaginosis (BV) in women undergoing vaginal microbiome transplantation. It aims to determine if the penile microbiome contributes to BV recurrence and whether disinfection using chlorhexidine gluconate can eliminate BV-associated bacteria. The study involves male partners of women who are participating in a related vaginal microbiome transplantation study and requires adherence to a condom use protocol. The findings could provide insights into the sexual transmission dynamics of BV.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The subject has s female partner who participates in VMT study ( NCT04517487).
* The subject is defined by the woman as her male regular partner.
* Willing to use a condom as instructed by the protocol.
* Willing to comply with decolonization protocol.

Exclusion Criteria:

* A known skin disease involving the penile skin.
* A known sensitivity to chlorhexidine gluconate
* Any of the partners (female/male) has more than one sexual partner.

Where it's running

• Hadassah Medical Center
  Jerusalem, Israel Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GenSci142 as a vaginal treatment for bacterial vaginosis

  This study tests whether GenSci142 given as vaginal doses is safe and may help BV patients aged 18–50 compared with clindamycin cream.

  Recruiting at 9 sites Phase 1 Changchun GeneScience Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 8 other locations · NCT07663838

• Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide

  This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07429864

• Vaginal gel to treat and prevent bacterial vaginosis and yeast infections

  This trial will test whether a vaginal gel called Multi-Gyn FemiTotal can treat and prevent bacterial vaginosis and vulvovaginal candidiasis in adult women.

  Recruiting Karo Pharma AB · Quatre Bornes · NCT07234786

• Using a device to treat bacterial vaginosis and fungal infections in women

  This study tests if a new medical device can help premenopausal women get rid of bacterial vaginosis and fungal infections.

  Recruiting at 3 sites Cern Corporation · Irvine, California and 2 other locations · NCT06933420

• Nasal microbiota transplant to restore infant nasal microbiome after intranasal mupirocin

  This trial will try a parent-to-child nasal microbiota transplant to see if it restores nasal microbial diversity in newborns after intranasal mupirocin treatment for S. aureus.

  Recruiting Phase 1 Johns Hopkins University · Baltimore, Maryland · NCT06805994

• Exploring how visiting green areas affects the human microbiome

  This study is testing whether spending time in green spaces can change the bacteria on our skin and in our noses for both kids and adults.

  Recruiting Universiteit Antwerpen · Antwerp · NCT06574724

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.